Assessing CV risk in patients with type 2 diabetes: SCORE-2 diabetes

14 April 2023 (08:30 - 08:42)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Emanuele Di Angelantonio

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

This programme is supported by Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor

Presentation thumbnail

Assessing CV risk in patients with type 2 diabetes: lessons learned from imaging

Professor J. Pitha (Prague, CZ)

Presentation thumbnail

Diabetes, microangiopathy and macroangiopathy: how are they related?

Professor C. Stehouwer (Maastricht, NL)

Presentation thumbnail

Exercise in patients with T2D: how to manage

Professor D. Hansen (Hasselt, BE)

Presentation thumbnail

Discussion – Cardiovascular risk in type 2 diabetes mellitus: how to assess and, how to manage?

Access the full session

Session thumbnail

Cardiovascular risk in type 2 diabetes mellitus: how to assess and, how to manage?

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 08:30 CET

You may be interested in

Congress Presentation

SCORE2-diabetes for personalising risk prediction

27 August 2023

Congress Session

Methods toolbox: cardiovascular risk estimation tools and therapy guidance

24 April 2026

Congress Presentation

Assessment of risk in diabetic patients.

29 August 2022

Congress Presentation

Geographic update of risk prediction tools for Asia: the challenges

14 April 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources